Skip to main content
Log in

Association of resistin polymorphisms with resistin levels and lipid profile in children

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Previous research has found a correlation between resistin and lipid level variations. Polymorphisms in the resistin gene (RETN) could be involved in this relationship, but the results of the different studies are contradictory. The aim of this study was to examine the association between resistin and lipid levels, and to determine whether resistin polymorphisms are associated with resistin levels and lipid profile in prepubertal children and adolescents. The single nucleotide polymorphisms (SNPs) rs1862513 and rs10401670 were analyzed in 442 randomly selected 6- to 8-year-old children and 827 children aged 12–16 years. Anthropometric data were recorded. Lipid profile was determined using standard methods. Serum resistin levels were measured using a multiplexed bead immunoassay. Resistin polymorphisms were determined by TaqMan® allelic discrimination assays. A relationship was found between serum levels of resistin and the SNP rs10401670 in 6- to 8-year-old boys. SNP rs10401670 was also related to TC and LDL-cholesterol in 12- to 16-year-old boys and to HDL-C in 12- to 16-year-old girls. SNP rs1862513 was not related to any of the studied variables. Serum resistin levels were significantly and negatively associated with ApoAI levels in 12- to 16-year-old girls. A SNP in the 3′UTR region of RETN (rs10401670) is associated with resistin levels and lipid profile in children, showing different associations depending on age and gender.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Szalowska E, Elferink MGL, Hoek A et al (2009) Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide. J ClinEndocrinolMetab 94:3051–3057

    Article  CAS  Google Scholar 

  2. Steppan CM, Lazar MA (2004) The current biology of resistin. J Intern Med 255:439–447

    Article  PubMed  CAS  Google Scholar 

  3. Lee S, Kim HS (2012) Human resistin in cardiovascular disease. J Smooth Muscle Res 48:27–35

    Article  PubMed  CAS  Google Scholar 

  4. Owecki M, Nikisch E, Miczke A et al (2010) Serum resistin is related to plasma HDL cholesterol and inversely correlated with LDL cholesterol in diabetic and obese humans. Neuro Endocrinol Lett 31:673–678

    PubMed  CAS  Google Scholar 

  5. Jové M, Planavila A, Cabrero A et al (2003) Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue. Metabolism 52:351–355

    Article  PubMed  Google Scholar 

  6. Asano H, Izawa H, Nagata K et al (2010) Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 53:234–246

    Article  PubMed  CAS  Google Scholar 

  7. Chen CC, Li TC, Li CI et al (2005) Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 54:471–475

    Article  PubMed  CAS  Google Scholar 

  8. Aquilante CL, Kosmiski LA, Knutsen SD et al (2008) Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism 57:494–501

    Article  PubMed  CAS  Google Scholar 

  9. de Luis DA, Gonzalez Sagrado M, Conde R et al (2009) Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diabetes Res ClinPract 84:174–178

    Article  Google Scholar 

  10. Norata GD, Ongari M, Garlaschelli K et al (2007) Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156:279–284

    Article  PubMed  CAS  Google Scholar 

  11. Uslu S, Kebapçi N, Kara M et al (2012) Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med 4:113–120

    PubMed  CAS  PubMed Central  Google Scholar 

  12. Roth CL, Kratz M, Ralston MM, Reinehr T (2011) Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism 60:445–452

    Article  PubMed  CAS  Google Scholar 

  13. Maggio AB, Wacker J, Montecucco F et al (2012) Serum resistin and inflammatory and endothelial activation markers in obese adolescents. J Pediatr 161:1022–1027

    Article  PubMed  CAS  Google Scholar 

  14. Gherlan I, Vladoiu S, Alexiu F et al (2012) Adipocytokine profile and insulin resistance in childhood obesity. Maedica (Buchar) 7:205–213

    Google Scholar 

  15. Rubin DA, McMurray RG, Hackney AC et al (2011) Relationship between cardiovascular risk factors and adipokines in adolescents. Horm Res Paediatr 76:123–129

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Boyraz M, Cekmez F, Karaoglu A et al (2013) Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children. Biomark Med 7:423–428

    Article  PubMed  CAS  Google Scholar 

  17. Menzhagui C, Coco A, Salvemini L et al (2006) Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 91:2792–2795

    Article  Google Scholar 

  18. Osawa H, Tabara Y, Kawamoto R et al (2007) Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C reactive protein in the Japanese general population. Diabetes Care 30:1501–1507

    Article  PubMed  CAS  Google Scholar 

  19. Cho YM, Youn B-S, Chung SS et al (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47:559–565

    Article  PubMed  CAS  Google Scholar 

  20. Azuma K, Oguchi S, Matsubara Y et al (2004) Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res 36:564–570

    Article  PubMed  CAS  Google Scholar 

  21. Lau CH, Muniandy S (2011) Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Ann Hum Genet 75:370–382

    Article  PubMed  CAS  Google Scholar 

  22. Ukkola O, Kunnari A, Kesäniemi YA (2008) Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul Pept 149:56–59

    Article  PubMed  CAS  Google Scholar 

  23. Hivert MF, Manning AK, McAteer JB et al (2009) Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes 58:750–756

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  24. EngertJC Vohl M-C, Williams SM et al (2002) 5´Flanking variants of resistin are associated with obesity. Diabetes 51:1629–1634

    Article  Google Scholar 

  25. Conneely KN, Silander K, Scott LJ et al (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47:1782–1788

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  26. Mattevi VS, Zembrzuski VM, Hutz MH (2004) A resistin gene polymorphism is associated with body mass index in women. Hum Genet 115:208–212

    Article  PubMed  CAS  Google Scholar 

  27. Kunnari A, Ukkola O, Kesäniemi YA (2005) Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med 22:583–589

    Article  PubMed  CAS  Google Scholar 

  28. Beckers S, Peeters AV, Freitas FD et al (2008) Analysis of genetic variations in the resistin gene shows no associations with obesity in women. Obesity 16:905–907

    Article  PubMed  CAS  Google Scholar 

  29. Cieslak J, Skorczyk A, Stachowiak M et al (2011) Polymorphisms in 5´-flanking regions of genes encoding adiponectin, leptin, and resistin are not associated with obesity of Polish children and adolescents. Mol Biol Rep 38:1793–1798

    Article  PubMed  CAS  Google Scholar 

  30. Carrascosa A, Fernández JM, Fernández A et al (2008) Spanish cross-sectional growth study. Part II. Height, weight and body mass index values from birth to adulthood. An Pediatr (Barc) 68:552–559

    Article  Google Scholar 

  31. Cole TJ, Bellizi CB, Flegal KM et al (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. Ortega L, Riestra P, Navarro P et al (2013) Resistin levels are related to fat mass, but not to body mass index in children. Peptides 49:49–52

    Article  PubMed  CAS  Google Scholar 

  33. BeckersS Zegers D, Van Camp JK et al (2013) Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study. Mol Biol Rep 40:2467–2472

    Article  Google Scholar 

  34. Smith SR, Bai F, Charbonneau C et al (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611–1618

    Article  PubMed  CAS  Google Scholar 

  35. Hasegawa G, Ohta M, Ichida Y et al (2005) Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 42:104–109

    Article  PubMed  CAS  Google Scholar 

  36. Tang NP, Wang LS, Yang L et al (2007) A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease. Clin Chem Lab Med 45:1471–1475

    Article  PubMed  CAS  Google Scholar 

  37. Boumaiza I, Omezzine A, Rejeb J et al (2012) Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Genet Test Mol Biomarkers 16:1356–1362

    Article  PubMed  CAS  Google Scholar 

  38. Costandi J, Melone M, Zhao A et al (2011) Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling. Circ Res 108:727–742

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The article is dedicated to the late Prof. Manuel de Oya as the warmest homage to his memory. Prof. de Oya designed the Four Province Study and the ideas reflected in our work can be traced back to his. This work was supported by a grant from the Fondo de Investigación Sanitaria (FIS 11/00344) and Biobank grant FEDER RD09/0076/00101. The contract of C Garcés is co-financed by the Fondo de Investigación Sanitaria. Lorena Ortega and Pilar Navarro are fellows of the Conchita Rábago Foundation. We thank Oliver Shaw for his revision of our manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmen Garcés.

Additional information

This article is dedicated to the late Prof. Manuel de Oya, as the warmest homage to his memory.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ortega, L., Navarro, P., Riestra, P. et al. Association of resistin polymorphisms with resistin levels and lipid profile in children. Mol Biol Rep 41, 7659–7664 (2014). https://doi.org/10.1007/s11033-014-3658-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3658-8

Keywords

Navigation